Injection of SCH 23390, but not 7-hydroxy-DPAT, into the ventral tegmental area blocks the acute motor-stimulant response to cocaine
Jeffery D. Steketee, B. C. Braswell
Abstract
Jeffery D. Steketee, B. C. Braswell
Abstract
The present studies examined the effects of intra-ventral tegmental area (VTA) injection of SCH 23390, a dopamine (DA) D1 receptor antagonist or 7-OH-DPAT, a DA D2/3 receptor agonist, on cocaine-stimulated motor activity. Intra-VTA SCH 23390 (1.5-15 nmol/side) dose-dependently blocked cocaine-induced motor activity. Thus, 15 nmol/side SCH 23390 completely blocked, while 5 nmol/side attenuated, the motor-stimulant response to cocaine. These doses of SCH 23390 did not alter basal motor activity, suggesting the effects on the motor-stimulant response to cocaine were not the result of a generalized suppression of activity. In contrast to previous studies, intra-VTA 7-OH-DPAT did not alter basal motor activity at any of the doses tested (0.5-15 nmol/side). In addition, intra-VTA 7-OH-DPAT (1.5-15 nmol/side) pretreatment did not significantly alter the motor-stimulant response to cocaine. These data suggest that DA D1 receptors in the VTA may play a role in psychostimulant-induced motor activity. However, the role DA D2/3 receptors in the VTA may have in cocaine-induced motor activity remains unclear.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The present studies examined the effects of intra-ventral tegmental area (VTA) injection of SCH 23390, a dopamine (DA) D1 receptor antagonist or 7-OH-DPAT, a DA D2/3 receptor agonist, on cocaine-stimulated motor activity. Intra-VTA SCH 23390 (1.5-15 nmol/side) dose-dependently blocked cocaine-induced motor activity. Thus, 15 nmol/side SCH 23390 completely blocked, while 5 nmol/side attenuated, the motor-stimulant response to cocaine. These doses of SCH 23390 did not alter basal motor activity, suggesting the effects on the motor-stimulant response to cocaine were not the result of a generalized suppression of activity. In contrast to previous studies, intra-VTA 7-OH-DPAT did not alter basal motor activity at any of the doses tested (0.5-15 nmol/side). In addition, intra-VTA 7-OH-DPAT (1.5-15 nmol/side) pretreatment did not significantly alter the motor-stimulant response to cocaine. These data suggest that DA D1 receptors in the VTA may play a role in psychostimulant-induced motor activity. However, the role DA D2/3 receptors in the VTA may have in cocaine-induced motor activity remains unclear.
Key concepts: Ventral tegmental area, SCH-23390, Stimulant, Dopamine, Agonist, Pharmacology, Chemistry, Internal medicine